Background
Respiratory Syncytial Virus (RSV) infects 70% of infants under one year, and is a leading cause of infant bronchiolitis-related hospitalizations [1, 2]. RSV is a relatively benign, temporary condition, and therefore likely to have limited impact on quality adjusted life years, however, it has potential for long-term consequences such as asthma and wheeze [3, 4]. Preferences related to the trade-offs between different long and short term aspects of RSV have not been explored previously, however, deriving preferences for infant health states is very challenging as infants require proxy elicitation of preferences [5–8].
Methods
The objectives of this study were to explore preferences surrounding attributes of RSV using proxy- and self-perspectives. Time trade-off (TTO) and best-worst scaling were used to derive utilities for health states of RSV and determine relative preferences for different levels of disease attributes. Vignettes were constructed from focus group data and expert opinion. Respondents were randomized to either a child perspective (“imagine that your child has RSV”), or an adult perspective (“imagine that you have RSV”). Experimental design for the BWS was developed using Sawtooth Software. 1000 Canadians were recruited through a market research panel facilitating a societal perspective. Five attributes were used – hospitalization status, oxygen support, presence of tubes (IV/NG), breathing symptom severity, and risk of long term wheeze. Ethics approval was obtained from the UBC BREB. Respondents completed both TTO and BWS tasks.
Results
Disutility associated with the short term health state of RSV was significant. Disutility followed an expected gradient, with more time traded for more severe RSV, and less time traded for less severe RSV (mean range: 0.57 – 0.14). Utilities were lower in the child perspective than the adult perspective. 0% risk of long term risk of wheeze was most preferred over all other attributes, and respiratory failure was least preferred (-4.7). Strong negative preferences were similar for IV/NG (-3.3), ICU admission (-3.5), mechanical ventilation (-3.6), and severe breathing problems (-3.6). Utility associated with risk of wheeze became lower as risk increased, with a relative preference for 80% risk of wheeze (-2.8) between moderate (-1.5) and severe (-3.7) breathing problems.
Conclusions
Preferences indicate societal willingness to accept immediate, short term, potentially clinically significant consequences to avoid long term risk of wheeze. This study provides utilities that can be utilized for the evaluation of any potential or proposed treatment of RSV in children, and is important to understanding and applying priorities in health care.
References
Chidgey SM, Broadley KJ: Respiratory syncytial virus infections: characteristics and treatment. J Pharm Pharmacol. 2005, 57: 1371-1381.
Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD: Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol. 1991, 133: 1135-1151.
Stensballe LG, Ravn H, Kristensen K, Agerskov K, Meakins T, Aaby P, Simões EAF: Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol. 2009, 123: 398-403.
Bont L, Steijn M, van Aalderen WMC, Kimpen JLL: Impact of Wheezing After Respiratory Syncytial Virus Infection on Health-Related Quality of Life. Pediatr Infect Dis J. 2004, 23: 414-417.
Prosser LA: Current Challenges and Future Research in Measuring Preferences for Pediatric Health Outcomes. J Pediatr. 2009, 155: 7-9.
Griebsch I: Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health. PEDIATRICS. 2005, 115: e600-e614.
Petrou S: Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ. 2003, 12: 697-702.
Ungar WJ: Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?. Pharmacoeconomics. 2011, 29: 641-652.
Acknowledgments
This study is funded by Abbott Laboratories and AllerGen NCE Canada.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Roy, L.M., Bansback, N., Marra, C. et al. Evaluating preferences for long term wheeze following RSV infection using TTO and best-worst scaling. All Asth Clin Immun 10 (Suppl 1), A64 (2014). https://doi.org/10.1186/1710-1492-10-S1-A64
Published:
DOI: https://doi.org/10.1186/1710-1492-10-S1-A64